JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neff, N. H.
Right arrow Articles by Costa, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neff, N. H.
Right arrow Articles by Costa, E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*DOPAMINE
*L-TYROSINE
*RESERPINE
*TRITIUM
Journal of Pharmacology And Experimental Therapeutics, Vol. 160, Issue 1, 40-47, 1968
Copyright © 1968 by American Society for Pharmacology and Experimental Therapeutics


APPLICATION OF STEADY-STATE KINETICS TO THE STUDY OF CATECHOLAMINE TURNOVER AFTER MONOAMINE OXIDASE INHIBITION OR RESERPINE ADMINISTRATION

N. H. Neff 1 and E. Costa 1

1 Departments of Pharmacology and Neurology, College of Physicians and Surgeons of Columbia University, New York

The present report suggests that a reciprocal relationship might exist between neuronal catecholamine concentrations and catecholamine turnover. This relationship was unmasked by studying the turnover rate of catecholamine stores with an isotopic and a nonisotopic method in rats treated with drugs that alter the steady-state levels of the catecholamines. Monoamine oxidase inhibitors increased the levels of norepinephrine (NE) and dopamine in brain and NE in heart and significantly decreased the turnover rates of these amines. The turnover rate of heart NE in rats given reserpine 6 or 8 days before measuring turnover was double that of control rats, whereas the NE levels were reduced by almost 30%.

Submitted on February 13, 1967
Accepted on November 6, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1968 by the American Society for Pharmacology and Experimental Therapeutics.